Planned Parenthood - Los Angeles S Mark Taper for Medical Training
Planned Parenthood - Los Angeles S Mark Taper for Medical Training was paid $10.57M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 11% of everything it billed.
LOS ANGELES, CA 90007
Next to other Community Health Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,841 | $1.75M | |
| 2019 | 51,296 | $1.60M | |
| 2020 | 29,233 | $847K | |
| 2021 | 31,666 | $1.09M | |
| 2022 | 42,346 | $1.61M | |
| 2023 | 54,668 | $2.10M | |
| 2024incomplete | 33,962 | $1.57M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 15,118 | 14,461 | $1.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.9% | 10,280 | 9,693 | $1.05M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9.1% | 20,985 | 20,047 | $966K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 9.0% | 1,096 | 1,096 | $946K |
| J3490 | Unclassified drugs | 8.8% | 33,218 | 28,948 | $935K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6.7% | 3,883 | 3,879 | $705K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.7% | 1,897 | 1,854 | $600K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.0% | 3,275 | 3,150 | $526K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.8% | 23,760 | 23,282 | $506K |
| S4993 | Contraceptive pills for birth control | 4.7% | 7,751 | 7,681 | $496K |
| 87806 | 3.6% | 17,460 | 14,817 | $379K | |
| 11981 | 2.8% | 1,124 | 1,124 | $300K |
43 more codes
| J7304 | Contraceptive supply, hormone containing patch, each | 2.6% | 834 | $275K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 23,737 | $266K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 2.1% | 545 | $227K |
| 99201 | 1.6% | 2,151 | $166K | |
| A4267 | Contraceptive supply, condom, male, each | 1.3% | 26,364 | $134K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 329 | $129K |
| 81025 | 1.1% | 32,467 | $120K | |
| 55250 | 1.1% | 808 | $120K | |
| 58300 | <1% | 759 | $89K | |
| 99401 | <1% | 3,931 | $75K | |
| 11976 | <1% | 910 | $57K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 4,115 | $52K |
| 99000 | <1% | 13,952 | $39K | |
| S5000 | Prescription drug, generic | <1% | 5,734 | $38K |
| 83986 | <1% | 10,649 | $26K | |
| 86703 | <1% | 2,744 | $23K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 482 | $17K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 4,409 | $16K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 3,327 | $15K |
| 86592 | <1% | 6,336 | $13K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 168 | $12K |
| 99402 | <1% | 284 | $9K | |
| 82120 | <1% | 3,770 | $9K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 226 | $9K |
| 87210 | <1% | 3,782 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 600 | $5K |
| 81002 | <1% | 2,577 | $5K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 192 | $4K |
| 58301 | <1% | 128 | $4K | |
| 85018 | <1% | 1,186 | $4K | |
| 11982 | <1% | 62 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 495 | $3K |
| 59840 | <1% | 24 | $2K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 14 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 137 | $1K |
| 86901 | <1% | 1,056 | $1K | |
| 36416 | <1% | 138 | $987.44 | |
| 99403 | <1% | 18 | $800.75 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 534 | $760.54 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 37 | $104.31 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 45 | $79.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13 | $52.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 96 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.